Published in Biol Psychiatry on July 26, 2007
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull (2008) 2.09
Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet (2013) 1.57
Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull (2009) 1.32
Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS One (2010) 1.24
Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies. Schizophr Bull (2012) 1.22
Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia. JAMA Psychiatry (2015) 1.19
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J Neurochem (2010) 1.14
Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol (2015) 1.14
Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophr Bull (2012) 1.09
Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophr Bull (2008) 1.05
Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density. Schizophr Bull (2012) 0.97
Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions. Am J Psychiatry (2010) 0.97
Auditory steady state response in the schizophrenia, first-degree relatives, and schizotypal personality disorder. Schizophr Res (2012) 0.87
Neuropathological changes in the substantia nigra in schizophrenia but not depression. Eur Arch Psychiatry Clin Neurosci (2013) 0.85
An Overview of the Association between Schizotypy and Dopamine. Front Psychiatry (2014) 0.84
Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological Targets. Front Psychiatry (2016) 0.84
Help-seeking in people with exceptional experiences: results from a general population sample. Front Public Health (2014) 0.83
Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: a tensor-based morphometry study. Hum Brain Mapp (2012) 0.81
Abnormal striatal dopamine transmission in schizophrenia. Curr Med Chem (2013) 0.81
How have developments in molecular imaging techniques furthered schizophrenia research? Imaging Med (2009) 0.77
Altered Cortico-Striatal Connectivity in Offspring of Schizophrenia Patients Relative to Offspring of Bipolar Patients and Controls. PLoS One (2016) 0.77
Striatal dopamine, reward, and decision making in schizophrenia. Dialogues Clin Neurosci (2016) 0.76
Common Variation in the DOPA Decarboxylase (DDC) Gene and Human Striatal DDC Activity In Vivo. Neuropsychopharmacology (2016) 0.76
Review of the 6th symposium for the search for the causes of schizophrenia, Sao Paulo, Brazil, 3-6 February 2009. Eur Arch Psychiatry Clin Neurosci (2009) 0.76
Attachment, Neurobiology, and Mentalizing along the Psychosis Continuum. Front Hum Neurosci (2016) 0.75
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry (2004) 2.92
Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome. Am J Psychiatry (2012) 2.79
MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry (2003) 2.51
Short-term diagnostic stability of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. Am J Psychiatry (2002) 2.38
Maternal smoking during pregnancy and regional brain volumes in preterm infants. J Pediatr (2009) 2.19
Early detection of the first episode of schizophrenia and suicidal behavior. Am J Psychiatry (2006) 1.85
Childhood bullying behavior and later psychiatric hospital and psychopharmacologic treatment: findings from the Finnish 1981 birth cohort study. Arch Gen Psychiatry (2009) 1.80
18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer. J Nucl Med (2008) 1.77
Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort. Early Interv Psychiatry (2010) 1.71
Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry (2005) 1.67
Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med (2010) 1.61
Neural correlates of declarative memory for emotionally valenced words in women with posttraumatic stress disorder related to early childhood sexual abuse. Biol Psychiatry (2003) 1.61
Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Heart (2010) 1.59
Childhood trauma and premorbid adjustment among individuals at clinical high risk for psychosis and normal control subjects. Early Interv Psychiatry (2012) 1.55
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. Eur J Nucl Med Mol Imaging (2008) 1.55
The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry (2005) 1.52
Radiosynthesis and evaluation of [18F]Selectfluor bis(triflate). Angew Chem Int Ed Engl (2010) 1.48
Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood. Arch Gen Psychiatry (2010) 1.46
The key to reducing duration of untreated first psychosis: information campaigns. Schizophr Bull (2007) 1.41
Childhood predictors of use and costs of antidepressant medication by age 24 years: findings from the Finnish Nationwide 1981 Birth Cohort Study. J Am Acad Child Adolesc Psychiatry (2011) 1.38
Who is at greatest risk of adverse long-term outcomes? The Finnish From a Boy to a Man study. J Am Acad Child Adolesc Psychiatry (2007) 1.38
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol Psychiatry (2002) 1.37
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J Clin Endocrinol Metab (2007) 1.34
Childhood predictors of completed and severe suicide attempts: findings from the Finnish 1981 Birth Cohort Study. Arch Gen Psychiatry (2009) 1.28
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant. Biol Psychiatry (2004) 1.28
Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol (2007) 1.27
Recruitment and treatment practices for help-seeking "prodromal" patients. Schizophr Bull (2007) 1.23
Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies. Eur Neuropsychopharmacol (2011) 1.21
The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics (2005) 1.19
Finnish Prenatal Study of Autism and Autism Spectrum Disorders (FIPS-A): overview and design. J Autism Dev Disord (2011) 1.18
Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull (2006) 1.17
Psychosocial risk factors associated with cyberbullying among adolescents: a population-based study. Arch Gen Psychiatry (2010) 1.17
Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol (2004) 1.17
Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord (2008) 1.15
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl) (2005) 1.14
Trajectory to a first episode of psychosis: a qualitative research study with families. Early Interv Psychiatry (2007) 1.14
Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis. Arch Gen Psychiatry (2008) 1.13
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
Increased brain fatty acid uptake in metabolic syndrome. Diabetes (2010) 1.10
C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse (2009) 1.10
Disability in people clinically at high risk of psychosis. Br J Psychiatry (2010) 1.10
Retracted Assessment of the hypothalamic-pituitary-adrenal axis over a 24-hour diurnal period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder. Biol Psychiatry (2003) 1.09
Personality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry (2003) 1.08
Childhood predictors of psychiatric disorders among boys: a prospective community-based follow-up study from age 8 years to early adulthood. J Am Acad Child Adolesc Psychiatry (2005) 1.08
Families' experience with seeking treatment for recent-onset psychosis. Psychiatr Serv (2009) 1.07
Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain. Mol Imaging Biol (2006) 1.07
Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage (2012) 1.07
The TIPS study and bias: replies to Dr Amos. Aust N Z J Psychiatry (2012) 1.07
64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats. Mol Imaging Biol (2014) 1.06
Stigma in families of individuals in early stages of psychotic illness: family stigma and early psychosis. Early Interv Psychiatry (2009) 1.06
The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse. Schizophr Res (2007) 1.05
Parental psychiatric disorders and autism spectrum disorders. Psychiatry Res (2013) 1.05
Axis-I disorders and vulnerability to psychosis. Schizophr Res (2004) 1.05
Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr Res (2012) 1.04
Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry (2004) 1.03
A qualitative research study of the evolution of symptoms in individuals identified as prodromal to psychosis. Psychiatr Q (2003) 1.03
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. J Cereb Blood Flow Metab (2008) 1.02
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region. J Cereb Blood Flow Metab (2006) 1.00
C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.00
Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([18F]SPA-RQ). Mol Imaging Biol (2004) 1.00
Childhood adversities, adult risk factors and depressiveness: a population study. Soc Psychiatry Psychiatr Epidemiol (2005) 1.00
Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease. J Nucl Med (2013) 1.00
First-episode psychosis: diagnostic stability over one and two years. Psychopathology (2008) 1.00
Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry (2008) 0.99
Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry (2005) 0.97
Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Res (2002) 0.95
Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain. Eur J Neurosci (2004) 0.94
Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180. J Nucl Med (2014) 0.94
Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging (2004) 0.93
Catalytic decarboxylative fluorination for the synthesis of tri- and difluoromethyl arenes. Org Lett (2013) 0.93